Metcash Limited falls 15% as dividend payout plunges: Should you buy?

Shares in Metcash Limited (ASX:MTS) have been taken to the cleaners on news its interim dividend will fall 31%.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

What: Shares in Metcash Limited (ASX: MTS) have been crushed as the group's underlying profit fell 9%, for the half-year ended 31 October 2014.

With shares down 15% at midday, Metcash shareholders have also had to digest news of a big cut to its interim dividend. At just 6.5 cents per share, the payout is down 31.5% from a year ago.

Here are the key takeaways from today's result:

  • Sales revenue up 1% to $6.645 billion
  • EBIT of $165.8 million, down 10.9%
  • EBIT margin of 2.5%, down from 2.8% last year
  • Operating cash flow down 44.2% to $128 million
  • Earnings per share of 11.4 cents
  • Profit from ordinary activities after tax attributable to members down 5.2%, to $101.7 million

So what: Metcash is at the beginning of a much needed five-year transformation to its operations. Indeed it is facing further price deflation and intense competition from not only Australia's two largest grocers, Woolworths Limited (ASX: WOW) and Coles – owned by Wesfarmers Ltd (ASX: WES), but also foreign giants, such as Aldi.

Although some positives could be taken away from today's result – such as the sales increases from its Hardware and Automotive division – Metcash is facing a number of structural challenges in the near-term.

Now what: CEO Ian Morrice said: "Six months into the Transformation Plan, Metcash is in a better position to provide guidance on FY15 earnings, given the now likely timing of initiatives and investment. FY15 Group EBIT is anticipated to be $315- $330 million." Implying a rather flat second half result.

Should you buy?

Whilst there are some encouraging signs from the group's first half results, it is facing the prospect of further pressures on its profit margins as competition increases and prices fall. At $2.20 per share, Metcash trades on a forward P/E ratio of just 10 and forecast dividend yield of slightly more than 6% fully franked. Although this may look cheap, in my opinion, long-term investors would be wise to steer clear of the stock until we get a greater insight into the success of its turnaround strategy.

As Warren Buffett famously said: "Turnarounds seldom turn."

Motley Fool Contributor Owen Raszkiewicz does not have a financial interest in any of the mentioned companies. 

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »